Dechra has now released its full year results for the year ending 2014. Revenues across both business segments increased, with European pharmaceuticals up £3.8M and US pharmaceuticals up £300K. Revenues also increased across most product categories with Food Animals the … Continue reading
Dechra have now released their half year results for the year ending 2014. European revenues increased by a rather meagre £4M with US revenues remaining roughly flat. The cost of sales, however, also reduced, by £2.4M to give a … Continue reading
Dechra have now released their half year results for the year ending 2013. I will start with the income statement. Starting with the revenue, we see that this is up across the board and in particular, revenues in Europe … Continue reading
Dechra Pharmaceuticals is an animal pharmaceuticals company who sells products to both the companion animal and farm animal markets. These results will be dominated by the recent acquisition and I will start by looking at the income report. The total … Continue reading
Dechra House, Jamage Industrial Estate, Talke Pits, Stoke on Trent, ST7 1XW Next up for my shares blog is Dechra Pharmaceuticals. Dechra is an international pharmaceutical business focussed on the veterinary market with its key area of specialisation being the … Continue reading